ACM
MD icon

Acrisure Capital Management’s Pediatrix Medical MD Stock Holding History

Acrisure Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,732
Closed -$174K – 330
2022
Q4 		$174K Buy
+11,732
New +$191K 0.19% 209

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrisure Capital Management's MD Position: Q1 2023 in Review

Acrisure Capital Management sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 11,732 shares — an estimated $174K sold.

Acrisure Capital Management first reported a position in MD in Q4 2022 and held it in 1 quarter. The position peaked at $174K in Q4 2022. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • Acrisure Capital Management reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • Acrisure Capital Management sold 11,732 Pediatrix Medical shares in Q1 2023, an estimated $174K.
  • Acrisure Capital Management first reported a position in Pediatrix Medical in Q4 2022 and held it in 1 quarter.
  • Acrisure Capital Management's Pediatrix Medical position peaked at $174K in Q4 2022.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on Acrisure Capital Management's 13F filing for Q1 2023, filed 15 May 2023.